Open AccessDiffuse goitre enlargement after immunotherapy for non‐small cell lung cancer
Author(s) -
Fujita Kohei,
Araki Norio,
Mio Tadashi
Publication year - 2021
Publication title -
respirology case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.304
H-Index - 9
ISSN - 2051-3380
DOI - 10.1002/rcr2.866
Subject(s) - medicine , immunotherapy , lung cancer , cancer immunotherapy , disease , lung , immune system , cancer research , oncology , immunology
Key message It is well known that a phenomenon called hyperprogressive disease (HPD) often occurs during immunotherapy with immune checkpoint inhibitors. In the present case, we experienced a case of HPD in a potential metastatic thyroid tumour during immunotherapy. HPD can be life‐threatening depending on where it appears, so clinicians need to be careful.